COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Hiroshi Ohtsu
Institution
National Center for Global Health and Medicine
Address
Tokyo
Japan
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2002
10
2003
3
2004
4
2005
6
2006
9
2007
4
2008
9
2009
9
2010
10
2011
11
2012
10
2013
13
2014
9
2015
8
2016
7
2017
8
2018
5
2019
1
2020
1
2021
5
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Matsunaga N
,
Hayakawa K
,
Terada M
,
Ohtsu H
,
Asai Y
,
Tsuzuki S
,
Suzuki S
,
Toyoda A
,
Suzuki K
,
Endo M
,
Fujii N
,
Suzuki M
,
Saito S
,
Uemura Y
,
Shibata T
,
Kondo M
,
Izumi K
,
Terada-Hirashima J
,
Mikami A
,
Sugiura W
,
Ohmagari N
. Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan. Clin Infect Dis. 2021 12 06; 73(11):e3677-e3689.
PMID:
32986793
.
Citations:
27
Fields:
Com
Communicable Diseases
Translation:
Humans
Tsuboi M
,
Hachiya M
,
Ohtsu H
,
Akashi H
,
Miyoshi C
,
Umeda T
. Epidemiology and risk of COVID-19 among travelers at airport and port quarantine stations across Japan: a nationwide descriptive analysis and an individually matched case-control study. Clin Infect Dis. 2021 Jul 28.
PMID:
34318872
.
Citations:
Fields:
Com
Communicable Diseases
Togano T
,
Uemura Y
,
Asai Y
,
Hayakawa K
,
Matsunaga N
,
Terada M
,
Ohtsu H
,
Suzuki S
,
Toyoda A
,
Hara H
,
Sato R
,
Ishikane M
,
Kinoshita-Iwamoto N
,
Hangaishi A
,
Ohmagari N
. The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Oct; 27(10):1498-1503.
PMID:
34340930
.
Citations:
1
Fields:
Ant
Anti-Infective Agents
Com
Communicable Diseases
Dru
Drug Therapy
Mic
Microbiology
Translation:
Humans
Terada M
,
Ohtsu H
,
Saito S
,
Hayakawa K
,
Tsuzuki S
,
Asai Y
,
Matsunaga N
,
Kutsuna S
,
Sugiura W
,
Ohmagari N
. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ Open. 2021 06 15; 11(6):e047007.
PMID:
34130961
.
Citations:
3
Fields:
Med
Medicine (General)
Translation:
Humans
Yamada G
,
Hayakawa K
,
Asai Y
,
Matsunaga N
,
Ohtsu H
,
Hojo M
,
Hashimoto M
,
Kobayashi K
,
Sasaki R
,
Okamoto T
,
Yanagawa Y
,
Katagiri D
,
Terada M
,
Suzuki M
,
Sato L
,
Miyazato Y
,
Ishikane M
,
Morioka S
,
Saito S
,
Ohmagari N
. External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Jul; 27(7):1043-1050.
PMID:
33865699
.
Citations:
Fields:
Ant
Anti-Infective Agents
Com
Communicable Diseases
Dru
Drug Therapy
Mic
Microbiology
Translation:
Humans
Saito S
,
Asai Y
,
Matsunaga N
,
Hayakawa K
,
Terada M
,
Ohtsu H
,
Tsuzuki S
,
Ohmagari N
. First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics. J Infect. 2021 04; 82(4):84-123.
PMID:
33152376
.
Citations:
41
Fields:
Com
Communicable Diseases
Translation:
Humans
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs